Andrew Badrot

The production of safe and effective medicines requires access to reliable manufacturers of APIs. However, increasing pressure to reduce market prices of drugs has created deeper challenges for API sourcing organizations, often leading them to consider lower quality and less reliable suppliers. This is a short-sighted approach. Particularly as global quality standards become more harmonized, there are now higher expectations across the globe. And with COVID-19, reliability has also become a top-of-mind topic for manufacturers and healthcare systems.

Optimizing the Total Cost of Ownership for APIs

The best approach to overcoming these challenges is finding a balance in the total cost of manufacturing and selling medicines, also referred to as total cost of ownership, with the right quality API at the right (not cheapest) price.

Pharmaceutical Technology’s October 2023 Trends in Formulation eBook

When referring to this article, please cite it as Badrot, A. Optimizing the Total Cost of Ownership for APIs. 

Pharmaceutical Technology’s Trends in Formulation eBook 

Articles

All members of the pharmaceutical supply chain must implement reliable sourcing and manufacturing strategies that balance quality and costs to ensure the uninterrupted supply of high-quality medicines to patients worldwide.